
|Podcasts|August 19, 2021
Episode 89: Cellicon Valley Outlook
Author(s)Elaine Quilici, Miranda Schmalfuhs
Audrey Greenberg, co-founder and executive managing director of the Center for Breakthrough Medicines and Discovery Labs, discusses how cell and gene therapy has turned Philadelphia into Cellicon Valley, and how her organization is playing a role in that growth even beyond the city’s borders.
Advertisement
Audrey Greenberg, co-founder and executive managing director of the Center for Breakthrough Medicines and Discovery Labs, discusses how cell and gene therapy has turned Philadelphia into Cellicon Valley, and how her organization is playing a role in that growth even beyond the city’s borders.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Executive Order Cuts Recommended Childhood Vaccines Down to 11: Report
2
Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors
3
BeOne Medicines Enters Collaboration with Revolution Medicines for Oncology Therapies
4
What 40 Conversations About a Pandemic Taught Me About How Pharma Communicates
5
